Ligand validation:3BIV

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3BIV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3BIV_NAG_H_1	30%	49%	0.16	0.823	0.75	1.2	-	3	8	0	100%	0.9333
3VXE_NAG_H_300	97%	28%	0.052	0.966	1.05	1.83	1	2	0	0	100%	0.9333
4AYV_NAG_B_1259	59%	55%	0.092	0.873	0.58	1.16	-	3	0	0	100%	0.9333
4LZ4_NAG_B_301	53%	24%	0.104	0.864	0.6	2.45	-	5	0	0	100%	0.9333
4E7R_NAG_G_1301	51%	23%	0.122	0.876	1.98	1.24	5	2	1	0	100%	0.9333
8ASE_NAG_B_303	50%	26%	0.14	0.888	0.9	2.08	-	3	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.